Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3813

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3813 3)

Label for Atorvastatin Calcium 10 mg tablets by NuCare Pharmaceuticals, Inc., manufactured by Apotex Inc. The label indicates a package of 30 film-coated tablets, with an oval, biconvex white to off-white tablet engraved "APO" on one side and "A10" on the other. It includes storage instructions, warnings, and regulatory barcodes.*

FDA Label Image

Figure-01 (Figure 01)

A line graph comparing the cumulative incidence (%) over time in years for Atorvastatin versus placebo. The x-axis represents time in years up to 3.5 years, and the y-axis shows cumulative incidence percentage reaching up to 4%. The graph includes hazard ratio (HR=0.64 with 95% confidence interval 0.50-0.83) and a p-value of 0.0005.*

FDA Label Image

Figure-02 (Figure 02)

A line graph comparing cumulative hazard percentages over time for placebo and Atorvastatin treatment. The x-axis represents time in years up to four years of follow-up, and the y-axis shows cumulative hazard percentages up to 15%. Atorvastatin's line is below placebo, indicating lower cumulative hazard, with hazard ratio and p-value noted.*

FDA Label Image

Figure-03 (Figure 03)

A line graph comparing time to first major cardiovascular endpoint over 5 years for subjects taking Atorvastatin 10 mg and 80 mg. The x-axis represents years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR 0.78) with confidence intervals and p-value, illustrating differences between the two dosage groups.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of atorvastatin calcium, the active ingredient in ATORVASTATIN CALCIUM tablets. The diagram shows the molecular arrangement including calcium ions and associated chemical groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.